Veranova

Dr. Kishore Hotha is a distinguished leader in the pharmaceutical biotech and CDMO sectors, with a strong track record in advancing drug substance and product development across small and large molecules, including Antibody-Drug Conjugates (ADCs), oligonucleotides, peptides, and complex formulations. Throughout his career, he has been pivotal in the submission of numerous INDs, NDAs, and ANDAs, guiding these projects from concept to commercialization. He holds a Ph.D. from Jawaharlal Nehru Technological University and an MBA from Southern New Hampshire University.

Currently, Dr. Hotha is the President of Dr. Hotha’s Life Sciences LLC, a consulting firm dedicated to simplifying complex drug development challenges. Previously, he served as Global Vice President at Veranova, where he led analytical research and development operations, and held significant leadership roles at Lupin and Dr. Reddy’s Laboratories. With over 50 publications and several editorial board positions, Dr. Hotha remains an influential figure in shaping industry standards and advancing pharmaceutical innovation.